Adjuavnt tyrosinase peptide vaccination in patients with resected stage III/IV melanoma.

被引：0
作者：
Letsch, A.
Scheibenbogen, C.
Fluck, M.
Asemissen, A.
Nagorsen, D.
Thiel, E.
Keilholz, U.
机构：
[1] CBF, Charite, Hematol & Oncol, Berlin, Germany
[2] Fachklin Hornheide, Munster, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：117S / 117S
页数：1
相关论文
共 50 条
[41]   Effects of ipilimumab on expanded tumor-infiltrating lymphocytes in patients with stage IV malignant melanoma. [J].
Bloom, Jon ;
Donia, Marco ;
Andersen, Rikke ;
Hadrup, Sine Raker ;
Lyngaa, Rikke ;
Svane, Inge Marie .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[42]   Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma. [J].
Wargo, Jennifer Ann ;
Amaria, Rodabe Navroze ;
Ross, Merrick I. ;
Saw, Robyn P. M. ;
Gershenwald, Jeffrey E. ;
Hwu, Patrick ;
Patel, Sapna Pradyuman ;
Glitza, Isabella Claudia ;
Diab, Adi ;
Kefford, Richard ;
Scolyer, Richard A. ;
Rizos, Helen ;
Thompson, John F. ;
Shannon, Kerwin ;
Spillane, Andrew ;
Carlino, Matteo S. ;
Guminski, Alex ;
Simpson, Lauren ;
Davies, Michael A. ;
Long, Georgina V. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[43]   Final results of a pilot study using sunitinib malate in patients with stage IV uveal melanoma. [J].
Tijani, L. A. ;
Luadadio, M. ;
Mastrangelo, M. J. ;
Sato, T. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[44]   Clinical relevance of PET scan in stage III & IV melanoma patients [J].
Stas, M ;
Stroobants, S ;
Dupont, P ;
Gysen, M ;
Van Hoe, L ;
Mulier, S ;
Garmyn, M ;
De Wever, I .
EUROPEAN JOURNAL OF CANCER, 1999, 35 :S370-S370
[45]   EPIDEMIOLOGY, TREATMENT PATTERNS AND COSTS IN PATIENTS WITH STAGE III/IV MELANOMA [J].
Lugowska, I ;
Szkutecka-Debek, M. ;
Sozanska-Solak, A. ;
Ziobro, M. ;
Wysocki, P. ;
Barszcz, E. ;
Jakubczyk, M. ;
Niewada, M. .
VALUE IN HEALTH, 2012, 15 (04) :A215-A215
[46]   Disparities in use of immunotherapy for stage III and IV melanoma patients. [J].
White, Richard L. ;
Trufan, Sally Jeanne ;
Gower, Nicole Lee ;
Neelands, Brittany ;
Amin, Asim .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[47]   The Proportion Cured of Patients with Resected Stage II-III Cutaneous Melanoma in Sweden [J].
Eriksson, Hanna ;
Utjes, Deborah ;
Olofsson Bagge, Roger ;
Gillgren, Peter ;
Isaksson, Karolin ;
Lapins, Jan ;
Schultz, Inkeri Leonardsson ;
Lyth, Johan ;
Andersson, Therese M. -L. .
CANCERS, 2021, 13 (10)
[48]   Biomarkers in melanoma: Stage III and IV disease [J].
Linette, GP ;
Carlson, JA ;
Slominski, A ;
Mihm, MC ;
Ross, JS .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2005, 5 (01) :65-74
[49]   Detection of melanoma cells in peripheral blood by tyrosinase RT-PCR in patients with malignant melanoma. [J].
Hochberg, M ;
Lotem, M ;
Shiloni, E ;
Enk, CD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) :574-574
[50]   Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial) [J].
Ridolfi, Laura ;
de Rosa, Francesco ;
Fiammenghi, Laura ;
Petrini, Massimiliano ;
Granato, Anna Maria ;
Ancarani, Valentina ;
Pancisi, Elena ;
Soldati, Valentina ;
Cassan, Serena ;
Bulgarelli, Jenny ;
Riccobon, Angela ;
Gentili, Giorgia ;
Nanni, Oriana ;
Framarini, Massimo ;
Tauceri, Francesca ;
Guidoboni, Massimo .
BMJ OPEN, 2018, 8 (08)
12345